Stock Events

Stock Events

Search...

Curative Biosciences

$0

17

+$0+0% Thursday 20:00

Statistics

Day High

0

Day Low

0

52W High

0

52W Low

0

Volume

10,000

Avg. Volume

403

Mkt Cap

128,946

P/E Ratio

0

Dividend Yield

-

Dividend

-

Earnings

15MayConfirmed

Q3 2016

Q4 2016

Q2 2017

Q3 2017

Q3 2017

Q4 2017

Q1 2018

-0.03

-0.02

-0.01

-0

Expected EPS

N/A

Actual EPS

-0.0016

People Also Follow

This list is based on the watchlists of people on Stock Events who follow CBDX. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

Cronos Group is involved in the production and sale of cannabis and cannabis-derived products, making it a competitor in the broader cannabis market.

Tilray is a global leader in cannabis research, cultivation, processing, and distribution, posing competition in both medicinal and recreational cannabis sectors.

Canopy Growth Corporation operates in the cannabis and hemp business, directly competing with Curative Biosciences in the cannabinoid product market.

Aurora Cannabis

Aurora Cannabis is engaged in the production and distribution of medical cannabis, competing in the medical cannabis sector.

Curaleaf Holdings operates in the cannabis retail and wholesale space, making it a competitor by offering cannabis products in markets where Curative Biosciences operates.

About

Pharmaceuticals: Other

Health Technology

Manufacturing

Dog and Cat Food Manufacturing

Curative Biosciences, Inc. focuses on developing and commercializing therapeutics using hemp-derived Cannabidiol. It intends to manufacture and market natural health products and operate in the medical cannabis industry. The company was formerly known as Amaize Beverage Corporation and changed its name to Curative Biosciences, Inc. in August 2017. Curative Biosciences, Inc. was founded in 2009 and is based in Miami, Florida.

Show more...

CEO

Country

US

ISIN

US23127M1018

Listings